When it comes to treating autoimmune diseases, recognizing the symptoms early is key. Maybe you first heard about an ...

A 35-year-old man presents with a chief complaint of purple discoloration of his toes and associated skin lesions that have ...

One of the most significant immune changes during menopause is an increase in pro-inflammatory cytokines, such as TNF-α and ...

Cohort A focused on patients with CLE or SLE with active lupus rash and evaluated organ-specific disease activity using the Cutaneous Lupus Erythematosus Disease Area and Severity Index Activity ...

Additionally, lupus moDCs engaged in crosstalk with TREM2+ macrophages, a lupus-specific skin resident population, through chemoattractant proteins as well as IL-10.Conclusion We thus propose that in ...

Lupus, an autoimmune disorder, presents skin manifestations like the butterfly rash, often mimicked by conditions such as ...

Enpatoran, a TLR7/8 inhibitor, demonstrated clinically meaningful improvements in disease activity among patients with ...

Nektar, which accused Lilly of making errors in its analysis of the data, forged ahead with the programme and started the ...

Merck, a leading science and technology company, today announced the presentation of detailed results from Cohort B of the global Phase 2 WILLOW study (NCT05162586) evaluating enpatoran, an ...

The FDA has approved a 200 mg/mL autoinjector of belimumab (Benlysta) for at-home subcutaneous use in children aged 5 years ...

Advanced practice providers can play a key role in providing patients with chronic lymphocytic leukemia with autoimmune disease testing and referring them to rheumatology when appropriate.